Skip to main content

Dermatology and Therapy OnlineFirst articles

Open Access 31-05-2024 | Review

Enhanced Insights into Frontal Fibrosing Alopecia: Advancements in Pathogenesis Understanding and Management Strategies

Frontal fibrosing alopecia (FFA) represents a distinctive form of primary lymphocytic scarring alopecia characterized by fronto-temporal hair recession and eyebrow hair loss. While predominantly affecting postmenopausal women, FFA also occurs in …

Authors:
Michela Starace, Stephano Cedirian, Luca Rapparini, Federico Quadrelli, Francesca Pampaloni, Francesca Bruni, Bianca M. Piraccini

Open Access 30-05-2024 | Vulgar Psoriasis | Correction

Correction to: Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

Authors:
A. Pinter, A. Costanzo, S. Khattri, S. D. Smith, J. M. Carrascosa, Y. Tada, E. Riedl, A. Reich, A. Brnabic, N. Haustrup, A. Lampropoulou, I. Lipkovich, Z. Kadziola, C. Paul, C. Schuster

Open Access 30-05-2024 | Vulgar Psoriasis | Correction

Correction to: Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe

Authors:
Anthony Bewley, Lauren Hiribarne, Jordi Galván, Sicily Mburu

Open Access 30-05-2024 | Skin Wrinkling | Original Research

Beneficial Effects of Multi-Micronutrient Supplementation with Collagen Peptides on Global Wrinkles, Skin Elasticity and Appearance in Healthy Female Subjects

Authors:
Rachael Gibson, Lieselotte Krug, David L. Ramsey, Azadeh Safaei, Sue Aspley

Open Access 30-05-2024 | Atopic Dermatitis | Review

A Multidisciplinary Approach Is Beneficial in Atopic Dermatitis

Atopic dermatitis (AD) is a highly heterogeneous chronic inflammatory skin disorder that is frequently associated with a plethora of comorbidities. AD is, therefore, considered a systemic disease impacted by a considerable burden and leading to …

Authors:
Paolo Amerio, Silvia Mariel Ferrucci, Marco Galluzzo, Maddalena Napolitano, Alessandra Narcisi, Anna Levi, Sara Di Fino, Chiara Palladino, Cataldo Patruno, Mariateresa Rossi

Open Access 30-05-2024 | Vulgar Psoriasis | Original Research

Ixekizumab Demonstrates Rapid and Consistent Efficacy for Patients with Psoriatic Arthritis, Regardless of Psoriasis Severity

Psoriatic arthritis (PsA) is a chronic inflammatory disease of the joints and tendons, typically associated with psoriasis of the skin and nails [ 1 ]. Approximately 20–30% of patients with psoriasis develop PsA, with the risk of developing PsA …

Authors:
April W. Armstrong, Tarannum Jaleel, Joseph F. Merola, Alice B. Gottlieb, Saakshi Khattri, Cameron C. Helt, William N. Malatestinic, Sarah E. Ross, Marcus E. Ngantcha, Kurt de Vlam

Open Access 27-05-2024 | Vulgar Psoriasis | Original Research

Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT

In the UPLIFT survey of patients with psoriasis and/or psoriatic arthritis in Japan, approximately 43% of patients with limited skin involvement (body surface area [BSA] ≤ 3%) self-reported moderate or severe disease [ 1 ]. Most patients with …

Authors:
Masatoshi Abe, Yukari Okubo, Hidetoshi Takahashi, Koki Endo, Siddharth Chaudhari, Cynthia Deignan, Hamid Amouzadeh, Ryosuke Hino

Open Access 26-05-2024 | Vulgar Psoriasis | Brief Report

Efficacy and Safety of Oxymatrine in the Treatment of Patients with Erythrodermic Psoriasis

Erythrodermic psoriasis (EP) is the least common but a severe type of psoriasis [ 1 ]. EP is characterized by erythema and scaling that affects more than 75% of the body surface area (BSA) [ 2 ] and is difficult to cure; multiple failed treatment …

Authors:
Huijuan Shi, Dongmei Chen, Jiawei Si, Qian Zou, Yatao Guo, Jiayu Yu, Cheng Li, Fang Wang

Open Access 24-05-2024 | Vulgar Psoriasis | Original Research

Treatment Discontinuation in Patients with Psoriasis Treated with Biologics: A Retrospective Analysis of German Health Claims Data

Plaque psoriasis is a common, often debilitating, chronic autoimmune inflammatory disease [ 1 ]. It has an incidence of 521.1 per 100,000 person years and, among adults, a lifetime prevalence of 2.2% in Germany [ 2 , 3 ]. According to the European …

Authors:
Andreas Pinter, Ahmed M. Soliman, Karina C. Manz, Valeria Weber, Paul Ludwig, Anja Mocek, Ariane Höer, Mark G. Lebwohl

Open Access 22-05-2024 | Atopic Dermatitis | Original Research

Baricitinib Improvement Across Regions in Atopic Dermatitis Patients with Baseline Body Surface Area up to 40% and Severe Itch

Atopic dermatitis (AD) is a chronic inflammatory skin disorder characterized by itch, eczema, excoriations, and lichenification of the skin [ 1 , 2 ]. Standard practice has largely approached AD as a monolithic disease [ 3 ]; however, the clinical …

Authors:
José-Manuel Carrascosa, Alessandra Narcisi, Toshifumi Nomura, Sonja Ständer, Christian Vestergaard, Silvia Sabatino, Susanne Grond, Uffe Koppelhus, Mohamed Elrayes, Yun-Fei Chen, Chunyuan Liu, Andreas Wollenberg

Open Access 19-05-2024 | Rheumatoid Arthritis | Review

Biologics Versus JAK Inhibitors. Part I: Cancer Risk. A Narrative Review

Conventional immunosuppressants such as corticosteroids, cyclosporine, methotrexate, or azathioprine present a significant burden of side effects (AEs) [ 1 ], including cytopenias (methotrexate or azathioprine), renal dysfunction or hypertension …

Authors:
Miguel Mansilla-Polo, Daniel Morgado-Carrasco

Open Access 17-05-2024 | Urticaria | Review

A Practical Approach to Diagnosing and Managing Chronic Spontaneous Urticaria

Chronic spontaneous urticaria (CSU) is an unpredictable inflammatory skin condition characterized by the spontaneous onset of itchy wheals, angioedema, or both, which occurs for longer than 6 weeks overall. Despite the relatively straightforward …

Authors:
Adam Friedman, Shawn G. Kwatra, Gil Yosipovitch

Open Access 17-05-2024 | Stevens-Johnson Syndrome | Original Research

Evaluation of the Factors Influencing Mortality in Patients with Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Multicenter Study of 166 Patients

Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are rare, life-threatening conditions that belong to the same disease spectrum. Clinically, they are characterized by widespread erythematous targetoid plaques accompanied by …

Authors:
Funda Erduran, Esra Adışen, Selma Emre, Yıldız Hayran, Emel Bülbül Başkan, Serkan Yazıcı, Aslı Bilgiç, Erkan Alpsoy, Sibel Doğan Günaydın, Leyla Elmas, Melih Akyol, RukiyeYasak Güner, Deniz Aksu Arıca, Yağmur Aypek, Tülin Ergun, Dilan Karavelioğlu, Ayça Cordan Yazıcı, Kübra Aydoğan, Dilek Bayramgürler, Rebiay Kıran, Hilal Kaya Erdoğan, Ersoy Acer, Akın Aktaş

Open Access 16-05-2024 | Vitiligo | Original Research

Patient Burden of Nonsegmental Vitiligo: A US Real-World Survey of Dermatologists and Their Patients

Vitiligo is a chronic autoimmune disease of the skin that targets melanocytes, causing patches of skin depigmentation [ 1 ]. The diagnosed prevalence of vitiligo is estimated to be approximately 0.1–1.5% of the US population (approximately 1.9 …

Authors:
David Rosmarin, Jennifer H. Lofland, Simran Marwaha, James Piercy, Peter Anderson, Jinan Liu

Open Access 15-05-2024 | Ixekizumab | Brief Report

Long-Term Effectiveness and Safety of Ixekizumab for the Treatment of Moderate-to-Severe Plaque Psoriasis: A Five-Year Multicenter Retrospective Study—IL PSO (Italian Landscape Psoriasis)

Psoriasis is an inflammatory skin disease that affects up to 2–3% of the worldwide population [ 1 ]. Psoriasis is considered a systemic disease that not only affects the skin but is often associated with several comorbidities, in particular …

Authors:
Mario Valenti, Luigi Gargiulo, Luciano Ibba, Piergiorgio Malagoli, Fabrizio Amoruso, Anna Balato, Federico Bardazzi, Martina Burlando, Carlo G. Carrera, Paolo Dapavo, Valentina Dini, Francesca M. Gaiani, Giampiero Girolomoni, Claudio Guarneri, Claudia Lasagni, Francesco Loconsole, Angelo V. Marzano, Martina Maurelli, Matteo Megna, Diego Orsini, Massimo Travaglini, Antonio Costanzo, Alessandra Narcisi

Open Access 14-05-2024 | Actinic Keratosis | Case Series

Anti-aging Effects of Tirbanibulin 1% Ointment: A Real-Life Experience

Actinic keratosis (AK) is a cutaneous intraepithelial neoplasm commonly arising in sun-exposed areas among adults, particularly on the face, scalp, and dorsal hands of predisposed individuals over the age of 40 [ 1 ]. Risk factors include older …

Authors:
Federica Li Pomi, Lucia Peterle, Andrea d’Aloja, Antonio Di Tano, Mario Vaccaro, Francesco Borgia

Open Access 13-05-2024 | Psoriatic Arthritis | Original Research

Enthesitis and Dactylitis Resolution with Risankizumab for Active Psoriatic Arthritis: Integrated Analysis of the Randomized KEEPsAKE 1 and 2 Trials

Enthesitis and dactylitis are common periarticular manifestations and are considered the cardinal musculoskeletal lesions in early active psoriatic arthritis (PsA) [ 1 – 3 ]. The worldwide prevalence of enthesitis and dactylitis in patients with …

Authors:
Shawn G. Kwatra, Saakshi Khattri, Ahmad Z. Amin, Roberto Ranza, Blair Kaplan, Linyu Shi, Byron Padilla, Ahmed M. Soliman, Dennis McGonagle

Open Access 08-03-2024 | Vulgar Psoriasis | Original Research

Burden of Topical Treatments in Psoriasis and Preferred Criteria of Choice: A Survey-Based Evaluation of Patients in Europe

Psoriasis is a chronic inflammatory skin disease that is estimated to affect up to 125 million people worldwide, up to one-third of whom will develop psoriatic arthritis [ 1 – 3 ]. The condition affects both males and females, although presentation …

Authors:
Anthony Bewley, Lauren Hiribarne, Jordi Galván, Sicily Mburu

Open Access 19-12-2023 | Original Research

Comparative Effectiveness and Durability of Biologics in Clinical Practice: Month 12 Outcomes from the International, Observational Psoriasis Study of Health Outcomes (PSoHO)

The development of biologic therapies has transformed the treatment of moderate-to-severe psoriasis (PsO) [ 1 , 2 ]. Yet, the chronic nature of psoriasis necessitates more studies showing the comparative effectiveness of biologics over longer …

Authors:
A. Pinter, A. Costanzo, S. Khattri, S. D. Smith, J. M. Carrascosa, Y. Tada, E. Riedl, A. Reich, A. Brnabic, N. Haustrup, A. Lampropoulou, I. Lipkovich, Z. Kadziola, C. Paul, C. Schuster